The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes
- PMID: 25617357
- PMCID: PMC4385997
- DOI: 10.1152/ajpheart.00414.2014
The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes
Abstract
AMP kinase (AMPK) plays an important role in the regulation of energy metabolism in cardiac cells. Furthermore, activation of AMPK protects the heart from myocardial infarction and heart failure. The present study examines whether or not AMPK affects the peroxisome proliferator-activated receptor-α (PPARα)/mitochondria pathway in response to acute oxidative stress in cultured cardiomyocytes. Cultured H9c2 rat embryonic cardioblasts were exposed to H2O2-induced acute oxidative stress in the presence or absence of metformin, compound C (AMPK inhibitor), GW6471 (PPARα inhibitor), or A-769662 (AMPK activator). Results showed that AMPK activation by metformin reverted oxidative stress-induced inactivation of AMPK and prevented oxidative stress-induced cell death. In addition, metformin attenuated reactive oxygen species generation and depolarization of the inner mitochondrial membrane. The antioxidative effects of metformin were associated with the prevention of mitochondrial DNA damage in cardiomyocytes. Coimmunoprecipitation studies revealed that metformin abolished oxidative stress-induced physical interactions between PPARα and cyclophilin D (CypD), and the abolishment of these interactions was associated with inhibition of permeability transition pore formation. The beneficial effects of metformin were not due to acetylation or phosphorylation of PPARα in response to oxidative stress. In conclusion, this study demonstrates that the protective effects of metformin-induced AMPK activation against oxidative stress converge on mitochondria and are mediated, at least in part, through the dissociation of PPARα-CypD interactions, independent of phosphorylation and acetylation of PPARα and CypD.
Keywords: AMPK; H9c2 cardiomyocytes; PPARα; metformin; mitochondria; oxidative stress.
Copyright © 2015 the American Physiological Society.
Figures
Similar articles
-
Metformin protects high glucose‑cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway.Mol Med Rep. 2020 Dec;22(6):5262-5270. doi: 10.3892/mmr.2020.11599. Epub 2020 Oct 14. Mol Med Rep. 2020. PMID: 33174032 Free PMC article.
-
Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs.Cardiovasc Diabetol. 2020 May 13;19(1):62. doi: 10.1186/s12933-020-01041-4. Cardiovasc Diabetol. 2020. PMID: 32404204 Free PMC article. Review.
-
The Combination Effect of Aspalathin and Phenylpyruvic Acid-2-O-β-D-glucoside from Rooibos against Hyperglycemia-Induced Cardiac Damage: An In Vitro Study.Nutrients. 2020 Apr 20;12(4):1151. doi: 10.3390/nu12041151. Nutrients. 2020. PMID: 32325968 Free PMC article.
-
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.Cardiovasc Drugs Ther. 2020 Apr;34(2):255-269. doi: 10.1007/s10557-020-06941-x. Cardiovasc Drugs Ther. 2020. PMID: 32034646 Free PMC article. Review.
-
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.Cardiovasc Res. 2010 Oct 1;88(1):67-74. doi: 10.1093/cvr/cvq113. Epub 2010 Apr 16. Cardiovasc Res. 2010. PMID: 20400621 Free PMC article.
Cited by
-
AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine.J Inflamm Res. 2023 Nov 21;16:5451-5464. doi: 10.2147/JIR.S441597. eCollection 2023. J Inflamm Res. 2023. PMID: 38026240 Free PMC article. Review.
-
Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment.Int J Mol Sci. 2023 Apr 22;24(9):7692. doi: 10.3390/ijms24097692. Int J Mol Sci. 2023. PMID: 37175399 Free PMC article. Review.
-
Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.J Cell Mol Med. 2022 Oct;26(19):4886-4903. doi: 10.1111/jcmm.17519. Epub 2022 Sep 2. J Cell Mol Med. 2022. PMID: 36052760 Free PMC article. Review.
-
Metformin Influence on the Intestinal Microbiota and Organism of Rats with Metabolic Syndrome.Int J Mol Sci. 2022 Jun 20;23(12):6837. doi: 10.3390/ijms23126837. Int J Mol Sci. 2022. PMID: 35743280 Free PMC article.
-
Thymoquinone ameliorates pressure overload-induced cardiac hypertrophy by activating the AMPK signalling pathway.J Cell Mol Med. 2022 Feb;26(3):855-867. doi: 10.1111/jcmm.17138. Epub 2021 Dec 24. J Cell Mol Med. 2022. PMID: 34953026 Free PMC article.
References
-
- Algire C, Moiseeva O, Deschenes-Simard X, Amrein L, Petruccelli L, Birman E, Viollet B, Ferbeyre G, Pollak MN. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev Res (Phila) 5: 536–543, 2012. - PubMed
-
- Barger PM, Browning AC, Garner AN, Kelly DP. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J Biol Chem 276: 44495–44501, 2001. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases